Target intelligence / Profile preview

Consciousness

Molecular classification
Other
01

Overview

Consciousness is an emergent physiological state characterized by arousal (wakefulness) and awareness (the content of experience), resulting from complex interactions within the central nervous system, particularly the thalamocortical system [1, 16]. Although not a single molecular target, receptor, or enzyme, it represents a primary clinical and therapeutic endpoint for pharmacological interventions in anesthesiology and psychiatry [4, 6]. The neurobiological basis of consciousness involves high-level integration of information across diverse brain regions, typically explained through frameworks such as the Global Neuronal Workspace Theory or Integrated Information Theory [7, 16]. Pharmacological modulation is primarily achieved by drugs that target ion channels and neurotransmitter receptors, such as GABA_A receptors for sedation, NMDA receptors for dissociation, or 5-HT2A receptors for altered states of awareness [4, 10, 18, 19]. Pathological alterations, known as Disorders of Consciousness (DoC), result from severe structural or metabolic brain injury and include conditions such as coma, vegetative states, and minimally conscious states [1, 4].

Other names
AwarenessWakefulnessSentienceArousalSubjective experience
02

Mechanism of action

Pharmacological modulation of consciousness is achieved through various molecular pathways that regulate neural integration and arousal, most notably the potentiation of inhibitory GABA_A receptors, the antagonism of excitatory NMDA-type glutamate receptors, and the agonism of cortical 5-HT2A serotonin receptors.

03

Biological functions

Cognitive processingInformation integrationSignal transductionArousalSensory perceptionOther
04

Disease associations

Traumatic brain injuryNeurodegenerative diseaseComaVegetative stateMinimally conscious stateEpilepsyOther
05

Safety considerations

Respiratory depressionPermanent cognitive impairmentPsychosisTolerance and dependenceAnesthesia-induced neurotoxicity
06

Interacting drugs

Propofol

7 more in the full profile.

07

Biomarkers

Electroencephalography (EEG) oscillationsPerturbational Complexity Index (PCI)Functional MRI (fMRI) connectivityGlasgow Coma Scale (GCS)

Beyond the preview

Go deeper on Consciousness.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Consciousness.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call